share_log

B. Riley Securities Maintains Neutral on Vaxart, Lowers Price Target to $1.5

B. Riley Securities Maintains Neutral on Vaxart, Lowers Price Target to $1.5

B. Riley Securities 对Vaxart保持中立,将目标价下调至1.5美元
Benzinga Real-time News ·  2022/12/19 08:31

B. Riley Securities analyst Mayank Mamtani maintains Vaxart (NASDAQ:VXRT) with a Neutral and lowers the price target from $6 to $1.5.

B.莱利证券分析师Mayank Mamtani维持Vaxart(纳斯达克:VXRT)中性,并将目标价从6美元下调至1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发